Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Yes — there is an active recall. 10 ongoing FDA recalls mention Olopatadine (13 total). Check the affected lots below.
Most common reason: cGMP deviation (5 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Olopatadine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Defective Delivery System: The dip tube is clogged causing the spray not to work.
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
CGMP Deviations:
CGMP Deviations:
CGMP Deviations:
CGMP Deviations:
CGMP Deviations:
CGMP Deviations: products were stored outside the drug label specifications.
Lack of Assurance of Sterility
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.